Michael Messenger

1.1k total citations
35 papers, 709 citations indexed

About

Michael Messenger is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Messenger has authored 35 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Messenger's work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Acute Kidney Injury Research (4 papers) and SARS-CoV-2 detection and testing (3 papers). Michael Messenger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (4 papers), Acute Kidney Injury Research (4 papers) and SARS-CoV-2 detection and testing (3 papers). Michael Messenger collaborates with scholars based in United Kingdom, United States and Switzerland. Michael Messenger's co-authors include Peter J. Selby, Rosamonde E. Banks, Douglas Thompson, Michael F. Loughlin, Paul Williams, Peter J. Jenks, Hernan P. Fainberg, Bethany Shinkins, David W. Ussery and Andrew Lewington and has published in prestigious journals such as Advanced Materials, Clinical Cancer Research and Journal of Bacteriology.

In The Last Decade

Michael Messenger

31 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Messenger United Kingdom	14	239	136	119	105	94	35	709
Jānis Gardovskis Latvia	16	215 0.9×	235 1.7×	145 1.2×	74 0.7×	118 1.3×	93	1.1k
Andrew Reid United Kingdom	15	289 1.2×	181 1.3×	101 0.8×	96 0.9×	99 1.1×	34	1.1k
Jihyang Lim South Korea	19	264 1.1×	244 1.8×	77 0.6×	71 0.7×	45 0.5×	114	1.3k
Chung Ying Leung China	7	175 0.7×	88 0.6×	30 0.3×	87 0.8×	85 0.9×	11	1.1k
Toralf Bernig Germany	16	202 0.8×	81 0.6×	62 0.5×	72 0.7×	58 0.6×	29	722
Paul J. Phelan Ireland	15	228 1.0×	165 1.2×	112 0.9×	78 0.7×	18 0.2×	52	905
Tillman Pearce United States	13	225 0.9×	225 1.7×	120 1.0×	128 1.2×	72 0.8×	35	789
Tommy R. Tong United States	20	347 1.5×	311 2.3×	287 2.4×	195 1.9×	126 1.3×	48	1.1k
Anita Aggarwal United States	17	141 0.6×	73 0.5×	155 1.3×	46 0.4×	25 0.3×	47	1.1k
Yongjung Park South Korea	20	236 1.0×	196 1.4×	255 2.1×	102 1.0×	90 1.0×	95	1.4k

Countries citing papers authored by Michael Messenger

Since Specialization

Citations

This map shows the geographic impact of Michael Messenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Messenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Messenger more than expected).

Fields of papers citing papers by Michael Messenger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Messenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Messenger. The network helps show where Michael Messenger may publish in the future.

Co-authorship network of co-authors of Michael Messenger

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Messenger. A scholar is included among the top collaborators of Michael Messenger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Messenger. Michael Messenger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huggett, Jim F., Denise M. O’Sullivan, Katell Peoc’h, et al.. (2025). An assessment of molecular diagnosis of tuberculosis and multi-drug resistant tuberculosis testing and quality assessment: findings of an international survey. Clinical Chemistry and Laboratory Medicine (CCLM). 63(11). 2341–2347.

Huggett, Jim F., Denise M. O’Sullivan, Simon Cowen, et al.. (2024). Ensuring accuracy in the development and application of nucleic acid amplification tests (NAATs) for infectious disease. Molecular Aspects of Medicine. 97. 101275–101275. 9 indexed citations

Honey, Stephanie, Richard D Neal, Michael Messenger, & Samuel G. Smith. (2022). Acceptability and experience of a personalised proteomic risk intervention for type 2 diabetes in primary care: qualitative interview study with patients and healthcare providers. Primary Health Care Research & Development. 23. e24–e24. 1 indexed citations

Messenger, Michael, et al.. (2021). Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications. International Journal of Technology Assessment in Health Care. 37(1). e68–e68. 4 indexed citations

Messenger, Michael, et al.. (2020). Target Product Profiles for medical tests: a systematic review of current methods. BMC Medicine. 18(1). 119–119. 31 indexed citations

Snaith, Beverly, M. Harris, Bethany Shinkins, et al.. (2019). Point of care creatinine testing in diagnostic imaging: A feasibility study within the outpatient computed tomography setting. European Journal of Radiology. 112. 82–87. 12 indexed citations

Vasudev, Naveen, Roisean E. Ferguson, Selina Bhattarai, et al.. (2019). UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time. Urology. 136. 162–168. 12 indexed citations

Walter, Fiona M, Matthew Thompson, Ian Wellwood, et al.. (2019). Evaluating diagnostic strategies for early detection of cancer: the CanTest framework. BMC Cancer. 19(1). 586–586. 38 indexed citations

Snaith, Beverly, et al.. (2018). Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility. Clinical Chemistry and Laboratory Medicine (CCLM). 56(8). 1269–1276. 29 indexed citations

10.

Cree, Ian A., Lesley Uttley, Helen Buckley Woods, et al.. (2017). The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review. BMC Cancer. 17(1). 697–697. 85 indexed citations

11.

Collinson, Fiona, Rachel A. Craven, David A. Cairns, et al.. (2013). Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection. Clinical Cancer Research. 19(18). 5227–5239. 58 indexed citations

12.

Aggarwal, S., et al.. (2013). Novel Reimbursement Models For Cancer Drug Market Access (2010-2013). Value in Health. 16(3). A153–A153. 1 indexed citations

13.

Smith, Matthew Welberry, Alexandre Zougman, David A. Cairns, et al.. (2013). Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation. Kidney International. 84(6). 1214–1225. 35 indexed citations

14.

Messenger, Michael, Walter M. Gregory, Naveen Vasudev, et al.. (2012). Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma. British Journal of Cancer. 107(7). 1131–1137. 50 indexed citations

15.

Messenger, Michael, et al.. (2011). Regenerative Medicine: A Snapshot of the Current Regulatory Environment and Standards. Advanced Materials. 23(12). H10–7. 10 indexed citations

16.

Messenger, Michael, et al.. (2011). Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences of metal ions. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 48(2). 112–120. 22 indexed citations

17.

Messenger, Michael, et al.. (2009). Enamel matrix derivative enhances tissue formation around scaffolds used for tissue engineering of ligaments. Journal of Tissue Engineering and Regenerative Medicine. 4(2). 96–104. 7 indexed citations

18.

Messenger, Michael, et al.. (2007). The Potential Use of Enamel Matrix Derivative for In Situ Anterior Cruciate Ligament Tissue Engineering: A Translational In Vitro Investigation. Tissue Engineering. 13(8). 2041–2051. 9 indexed citations

19.

Loughlin, Michael F., Hernan P. Fainberg, Michael Messenger, et al.. (2003). Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori. Molecular Microbiology. 51(1). 15–32. 98 indexed citations

20.

Messenger, Michael. (1981). A high technology-low energy demand for Western Europe. Energy. 6(12). 1481–1503. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact